BioLargo, Inc. 14921 Chestnut St. Westminster, CA 92683 Telephone: 888.400.2863 Facsimile: 949.625.9819 |
January 6, 2023
Jordan Nimitz
U.S. Securities & Exchange Commission
Division of Corporate Finance
100 F. Street NE
Washington, D.C. 20549
Re: | BioLargo, Inc. Registration Statement on Form S-1 Filed December 23, 2022 File No. 333-268973 |
WITHDRAWAL OF REQUEST FOR ACCELERATION OF EFFECTIVENESS
Dear Mr. Nimitz:
Reference is made to our letter, filed as correspondence via EDGAR on January 4, 2023, in which we requested the acceleration of the effective date of the above-referenced Registration Statement for Friday, January 6, 2023, at 5:00 p.m. Eastern Standard Time, in accordance with Rule 461 under the Securities Act of 1933, as amended. We are no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.
Very truly yours,
/s/Dennis P. Calvert
Dennis P. Calvert
President
BioLargo, Inc.
cc: Gilbert Bradshaw, Esq.